One-off PSA test may do more harm than good, largest study to date shows

It detects more early-stage, low-grade cancers but makes no difference to mortality

The largest prostate cancer screening study to date has found that a one-off test detects more early-stage, low-grade cancers but fails to make any difference to mortality.